Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-10-22 16:06:58
Reporting Period:
Accepted Time:
2019-10-22 16:06:58
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1510487 Principia Biopharma Inc. PRNB Pharmaceutical Preparations (2834) 263487603
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1752139 J. Daniel Becker C/o Principia Biopharma Inc.
220 E. Grand Avenue
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-18 535,000 $28.00 535,000 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
  1. Reflects shares of Common Stock of Principia Biopharma Inc. (the "Issuer") that were purchased in connection with the Issuer's public offering.
  2. The reported shares are held directly by AI Biotechnology LLC ("AIB"), a limited liability company of which the Reporting Person is the holder of units that are treated as profits interest units. The units owned by the Reporting Person do not convey a right to vote or dispose of the shares of the Issuer's Common Stock held by AIB. The Reporting Person disclaims beneficial ownership of all shares held by AIB and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose except to the extent of his pecuniary interest therein.